Predictors composed of mixed clinical and omic features were also considered, finding good and performance, confirmed in independent cohorts, for a fingerprint composed of three well known clinical parameters (PSA, Gleason primary score, and tumor stage) and expression levels for NF2 and CDKN1B. Here, CDKN1B is linked to neoplasm.